Calgary
Canada
11
2022-11-24
9
2026-02-17
These are the the leading inventors for applications assigned to Resverlogix Corp.:
Resverlogix Corp. based in Calgary, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR
#2 | 2021-03-11 ✅ Patent 11,407,719 granted on 2022-08-09Anti-inflammatory agents
#3 | 2019-04-25 ✅ Patent 10,882,828 granted on 2021-01-05Anti-inflammatory agents
#4 | 2017-05-04 ✅ Patent 10,016,426 granted on 2018-07-10Pharmaceutical compositions for substituted quinazolinones
#5 | 2016-12-01COMPOSITIONS AND THERAPEUTIC METHODS FOR ACCELERATED PLAQUE REGRESSION
#6 | 2016-05-19 ✅ Patent 10,131,640 granted on 2018-11-20Anti-inflammatory agents
#7 | 2016-04-21COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
#8 | 2014-04-17 ✅ Patent 8,884,046 granted on 2014-11-11Compounds useful in the synthesis of benzamide compounds
#9 | 2013-05-02 ✅ Patent 9,610,251 granted on 2017-04-04Pharmaceutical compositions for substituted quinazolinones
#10 | 2010-01-07 ✅ Patent 8,114,995 granted on 2012-02-14Methods of preparing quinazolinone derivatives
#11 | 2009-10-15 ✅ Patent 8,242,130 granted on 2012-08-14Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
Also check out Resverlogix Corp.'s (Calgary, Canada) applicant profile with 9 patent applications submitted.
20578 ⎘